Bing Ni from September 1999 to June 2002 worked on achieving M.D. and Ph.D. degrees in molecular immunology at the Third Military Medical University, Chongqing, China, with a research project entitled “Study of a novel genetic vaccines based on alpha virus vector.” He worked from September 1994 to June 1997 to receive an M.S. degree in medical biochemistry from Third Military Medical University, Chongqing, China, with a research project entitled “Isolation and purification of mouse 20S proteasome and preparation of the antiserum anti the proteasome: Study on the amount and activity of 20S proteasome in skeletal muscle of mice with serious burn.” From August 1986 to July 1992, he worked to obtain a B.S. degree in clinical medicine from the Third Military Medical University, Chongqing, China. Since May 2007, he has been working as a Professor, Doctoral Supervisor, Duty Director at the Institute of Immunology, PLA, Third Military Medical University; and as an Editorial Director of Immunological Journal, Chongqing, China. From February 2006 to MAy 2007, he served as a postdoctoral at the University of Toronto, University Health Network Ophthalmology, and Toronto Western Research Institute, Toronto, Ont, Canada. His research experiences are among the following. Since 2007, his research has been focusing on the mutual interaction between Treg and Th17 cells in hepatitis B model; research also focuses on the interacting proteins complexed with the critical transcription factors in Treg and Th17 cells. The interaction mechanisms between LTi cells and Treg/Th17 cells are also of the research targets. The epigenetic mechanisms involved in these cells and HBV-infected cells are being investigating as well. From 2006 to 2007, he had postdoctoral work in Rod‘s Laboratory in Toronto, Canada on a project entitled “Signature phenotypes in the early stage of retinoblastoma.” This research involves several signal pathways including Wnt, Notch, TGF-b, and PTEN.
Biography Updated on 28 March 2012